$.40's seems a stretch at least for today. But if it gets that low will rebuy shares.
Future for this ticker depends on what they do with their brand new US Patent. Sell it outright or use it as "bait" for a partnership with big Pharma? (imo)
Disclaimer: Do not rely on my projections or opinions to make a buy or sell decision. Always do your own DD.
Recent NCNA News
- NuCana Announces Completion of ADS Ratio Change • GlobeNewswire Inc. • 04/16/2024 12:00:00 PM
- NuCana Presents Data at the AACR 2024 Annual Meeting Highlighting the Ability of NUC-7738 to Profoundly Alter Tumor Biology in a Paired Biopsy Clinical Study • GlobeNewswire Inc. • 04/09/2024 08:30:00 PM
- NuCana Announces Plan to Implement ADS Ratio Change • GlobeNewswire Inc. • 03/27/2024 08:30:00 PM
- NuCana Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Business Update • GlobeNewswire Inc. • 03/20/2024 08:01:00 PM
- NuCana to Present at TD Cowen’s 44th Annual Health Care Conference • GlobeNewswire Inc. • 02/27/2024 01:00:00 PM
- NuCana to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference • GlobeNewswire Inc. • 02/06/2024 01:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/16/2023 09:08:52 PM
- NuCana Reports Third Quarter 2023 Financial Results and Provides Business Update • GlobeNewswire Inc. • 11/16/2023 09:01:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/13/2023 09:22:50 PM
- NuCana Announces Listing Transfer to Nasdaq Capital Market • GlobeNewswire Inc. • 11/10/2023 09:01:00 PM
- NuCana to Present at the Jefferies London Healthcare Conference • GlobeNewswire Inc. • 11/08/2023 09:01:00 PM
- NuCana to Participate in the Truist Securities 2023 BioPharma Symposium • GlobeNewswire Inc. • 11/01/2023 08:01:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 10/16/2023 11:10:58 AM
- NuCana Presents Promising Data on NUC-7738 at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 2023 • GlobeNewswire Inc. • 10/16/2023 11:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 10/13/2023 08:09:55 PM
- NuCana Presents Encouraging Data on NUC-3373 in Colorectal Cancer at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 2023 • GlobeNewswire Inc. • 10/13/2023 04:30:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/18/2023 12:10:56 PM
- NuCana Announces Presentations at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 2023 • GlobeNewswire Inc. • 09/18/2023 12:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/16/2023 08:08:42 PM
- NuCana Reports Second Quarter 2023 Financial Results and Provides Business Update • GlobeNewswire Inc. • 08/16/2023 08:01:00 PM
- NuCana to Present at the Jefferies Healthcare Conference • GlobeNewswire Inc. • 06/01/2023 12:00:00 PM
- NuCana Reports First Quarter 2023 Financial Results and Provides Business Update • GlobeNewswire Inc. • 05/17/2023 08:01:00 PM
- NuCana Announces Receipt of Nasdaq Notice • GlobeNewswire Inc. • 05/12/2023 08:01:00 PM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM